Palatin Technologies
PTN
#10700
Rank
ยฃ13.77 M
Marketcap
ยฃ7.74
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -ยฃ4.62 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ12.88 Million. In 2025 the company made an earning of -ยฃ7.11 Million, an increase over its 2024 earnings that were of -ยฃ19.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ4.62 Million-35.07%
2025 -ยฃ7.11 Million-64.29%
2024 -ยฃ19.91 Million-16.9%
2023 -ยฃ23.96 Million5.99%
2022 -ยฃ22.6 Million-13.7%
2021 -ยฃ26.19 Million33.25%
2020 -ยฃ19.66 Million-172.11%
2019 ยฃ27.25 M2352.33%
2018 ยฃ1.11 M-94.13%
2017 ยฃ18.93 M-154.92%
2016 -ยฃ34.48 Million3.67%
2015 -ยฃ33.26 Million878%
2014 -ยฃ3.41 Million-72.64%
2013 -ยฃ12.43 Million-33.11%
2012 -ยฃ18.59 Million77.71%
2011 -ยฃ10.46 Million
2003 -ยฃ17.71 Million29.93%
2002 -ยฃ13.63 Million36.18%
2001 -ยฃ10.01 Million
1999 -ยฃ8.31 Million6.04%
1998 -ยฃ7.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.19 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.83 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.59 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ8.66 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.14 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ86.93 Million 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ85.72 M-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ21.79 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ42.82 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA